416 related articles for article (PubMed ID: 33420027)
1. EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma.
Fang R; Chen X; Zhang S; Shi H; Ye Y; Shi H; Zou Z; Li P; Guo Q; Ma L; He C; Huang S
Nat Commun; 2021 Jan; 12(1):177. PubMed ID: 33420027
[TBL] [Abstract][Full Text] [Related]
2. The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes.
Huang K; Fang C; Yi K; Liu X; Qi H; Tan Y; Zhou J; Li Y; Liu M; Zhang Y; Yang J; Zhang J; Li M; Kang C
Theranostics; 2018; 8(6):1540-1557. PubMed ID: 29556340
[TBL] [Abstract][Full Text] [Related]
3. LPA
Valdés-Rives SA; Arcos-Montoya D; de la Fuente-Granada M; Zamora-Sánchez CJ; Arias-Romero LE; Villamar-Cruz O; Camacho-Arroyo I; Pérez-Tapia SM; González-Arenas A
Cells; 2021 Apr; 10(4):. PubMed ID: 33916643
[TBL] [Abstract][Full Text] [Related]
4. Exploring ncRNA-mediated regulation of EGFR signalling in glioblastoma: From mechanisms to therapeutics.
Thapa R; Afzal M; Goyal A; Gupta G; Bhat AA; Almalki WH; Kazmi I; Alzarea SI; Shahwan M; Kukreti N; Ali H; Dureja H; Kumar P; Singh TG; Kuppusamy G; Singh SK; Dua K
Life Sci; 2024 May; 345():122613. PubMed ID: 38582393
[TBL] [Abstract][Full Text] [Related]
5. GRIK1 promotes glioblastoma malignancy and is a novel prognostic factor of poor prognosis.
Hou G; Xu X; Hu W
Oncol Res; 2024; 32(4):727-736. PubMed ID: 38560566
[TBL] [Abstract][Full Text] [Related]
6. Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr.
Fedrigo CA; Grivicich I; Schunemann DP; Chemale IM; dos Santos D; Jacovas T; Boschetti PS; Jotz GP; Braga Filho A; da Rocha AB
Radiat Oncol; 2011 Nov; 6():156. PubMed ID: 22077956
[TBL] [Abstract][Full Text] [Related]
7. The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation.
Kosti A; de Araujo PR; Li WQ; Guardia GDA; Chiou J; Yi C; Ray D; Meliso F; Li YM; Delambre T; Qiao M; Burns SS; Lorbeer FK; Georgi F; Flosbach M; Klinnert S; Jenseit A; Lei X; Sandoval CR; Ha K; Zheng H; Pandey R; Gruslova A; Gupta YK; Brenner A; Kokovay E; Hughes TR; Morris QD; Galante PAF; Tiziani S; Penalva LOF
Genome Biol; 2020 Aug; 21(1):195. PubMed ID: 32762776
[TBL] [Abstract][Full Text] [Related]
8. NOVA1 acts as an oncogenic RNA-binding protein to regulate cholesterol homeostasis in human glioblastoma cells.
Saito Y; Yang Y; Saito M; Park CY; Funato K; Tabar V; Darnell RB
Proc Natl Acad Sci U S A; 2024 Mar; 121(10):e2314695121. PubMed ID: 38416679
[TBL] [Abstract][Full Text] [Related]
9. CHCHD2 mediates glioblastoma cell proliferation, mitochondrial metabolism, hypoxia‑induced invasion and therapeutic resistance.
Lumibao JC; Haak PL; Kolossov VL; Chen JE; Stutchman J; Ruiz A; Sivaguru M; Sarkaria JN; Harley BAC; Steelman AJ; Gaskins HR
Int J Oncol; 2023 Nov; 63(5):. PubMed ID: 37654190
[TBL] [Abstract][Full Text] [Related]
10. A leak pathway for luminal protons in endosomes drives oncogenic signalling in glioblastoma.
Kondapalli KC; Llongueras JP; Capilla-González V; Prasad H; Hack A; Smith C; Guerrero-Cázares H; Quiñones-Hinojosa A; Rao R
Nat Commun; 2015 Feb; 6():6289. PubMed ID: 25662504
[TBL] [Abstract][Full Text] [Related]
11. TMED2 promotes glioma tumorigenesis by being involved in EGFR recycling transport.
Sun C; Zhang Y; Wang Z; Chen J; Zhang J; Gu Y
Int J Biol Macromol; 2024 Mar; 262(Pt 2):130055. PubMed ID: 38354922
[TBL] [Abstract][Full Text] [Related]
12. EGFRvIII uses intrinsic and extrinsic mechanisms to reduce glioma adhesion and increase migration.
Banisadr A; Eick M; Beri P; Parisian AD; Yeoman B; Placone JK; Engler AJ; Furnari F
J Cell Sci; 2020 Dec; 133(24):. PubMed ID: 33243756
[TBL] [Abstract][Full Text] [Related]
13. SH3KBP1 Promotes Glioblastoma Tumorigenesis by Activating EGFR Signaling.
Song H; Wang Y; Shi C; Lu J; Yuan T; Wang X
Front Oncol; 2020; 10():583984. PubMed ID: 33643898
[TBL] [Abstract][Full Text] [Related]
14. Glioma glycolipid metabolism: MSI2-SNORD12B-FIP1L1-ZBTB4 feedback loop as a potential treatment target.
Dong W; Liu X; Yang C; Wang D; Xue Y; Ruan X; Zhang M; Song J; Cai H; Zheng J; Liu Y
Clin Transl Med; 2021 May; 11(5):e411. PubMed ID: 34047477
[TBL] [Abstract][Full Text] [Related]
15. Critical role of lncEPAT in coupling dysregulated EGFR pathway and histone H2A deubiquitination during glioblastoma tumorigenesis.
Li L; Zhou A; Wei Y; Liu F; Li P; Fang R; Ma L; Zhang S; Wang L; Liu J; Richard HT; Chen Y; Wang H; Huang S
Sci Adv; 2022 Oct; 8(40):eabn2571. PubMed ID: 36197973
[TBL] [Abstract][Full Text] [Related]
16. Synergistic anticancer effect by targeting CDK2 and EGFR-ERK signaling.
Wu J; Chen Y; Li R; Guan Y; Chen M; Yin H; Yang X; Jin M; Huang B; Ding X; Yang J; Wang Z; He Y; Wang Q; Luo J; Wang P; Mao Z; Huen MSY; Lou Z; Yuan J; Gong F
J Cell Biol; 2024 Jan; 223(1):. PubMed ID: 37955924
[TBL] [Abstract][Full Text] [Related]
17. Ribogenesis boosts controlled by HEATR1-MYC interplay promote transition into brain tumour growth.
Diaz LR; Gil-Ranedo J; Jaworek KJ; Nsek N; Marques JP; Costa E; Hilton DA; Bieluczyk H; Warrington O; Hanemann CO; Futschik ME; Bossing T; Barros CS
EMBO Rep; 2024 Jan; 25(1):168-197. PubMed ID: 38225354
[TBL] [Abstract][Full Text] [Related]
18. Loss of YTHDF2 Alters the Expression of m
Golubeva VA; Dorn LE; Gilbert CJ; Rabolli CP; Das AS; Wanasinghe VS; Veress R; Terentyev D; Accornero F
JACC Basic Transl Sci; 2023 Sep; 8(9):1180-1194. PubMed ID: 37791304
[TBL] [Abstract][Full Text] [Related]
19. Binding to m
Wang J; Wang L; Diao J; Shi YG; Shi Y; Ma H; Shen H
Protein Cell; 2020 Apr; 11(4):304-307. PubMed ID: 31642031
[No Abstract] [Full Text] [Related]
20. SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.
Hou G; Zhao X; Li L; Yang Q; Liu X; Huang C; Lu R; Chen R; Wang Y; Jiang B; Yu J
Nucleic Acids Res; 2021 Mar; 49(5):2859-2877. PubMed ID: 33577677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
